These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6971118)

  • 21. The diagnosis of cutaneous T-cell lymphoma by morphometric evaluation of the cellular infiltrate, using semithin sections.
    Lessana-Leibowitch M; Prado A; Palangie A; Lamy F; Flandrin G
    Br J Dermatol; 1984 May; 110(5):511-21. PubMed ID: 6609710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
    Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
    J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA analysis by flow cytometry in cutaneous T-cell lymphomas.
    Ralfkiaer E; Larsen JK; Christensen IJ; Thomsen K; Wantzin GL
    Br J Dermatol; 1989 May; 120(5):597-605. PubMed ID: 2788008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of surface markers and cytoplasmic organelle in benign and malignant lymphoid lesions of skin; immunohistochemical and electron microscopic evaluation.
    Jimbow K; Katoh M; Nishio C; Jimbow M
    J Cutan Pathol; 1981 Aug; 8(4):283-98. PubMed ID: 7309942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
    Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
    Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
    Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
    J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of primary cutaneous T-cell lymphoma in Norway.
    Saunes M; Nilsen TI; Johannesen TB
    Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF; Hensley LL; Jegasothy BV
    Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
    Arai E; Katayama I; Ishihara K
    Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.
    Schrader AM; Jansen PM; Willemze R
    Br J Dermatol; 2016 Aug; 175(2):382-6. PubMed ID: 26931394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.
    Chang MB; Weaver AL; Brewer JD
    Int J Dermatol; 2014 Aug; 53(8):966-70. PubMed ID: 24134412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
    Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcoidal tissue reaction in Sézary syndrome.
    Gregg PJ; Kantor GR; Telang GH; Lessin SR; Nowell PC; Vonderheid EC
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):372-6. PubMed ID: 10901727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.